An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from an English NHS perspective
17 April 2023 (16:40 - 17:40)
Organised by:
Abstract
Slides
About the speaker
Vancouver General Hospital, Vancouver (Canada)
7 More presentations in this session
Associate Professor N. Vandersickel (Ghent, BE)
Professor N. Reinsch (Essen, DE)
Doctor D. Della Rocca (Brussels, BE)
Doctor D. Tsiachris (Athens, GR)
Access the full session
The Event
EHRA 2023
17 April 2023
16:40 CET
You may be interested in
Congress Presentation
Congress Presentation
